Skip to main content
Katharine Batt, MD, Hematology, Raleigh, NC, Mission Hospital

KatharineBattMDMSc(She/Her)

Hematology Raleigh, NC

Clotting Disorder, Hemophilia & Bleeding Disorder

Scientific Advisor

Dr. Batt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Batt's full profile

Already have an account?

Education & Training

  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2010 - 2013
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Hospice and Palliative Medicine, 2009 - 2010
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2006 - 2009
  • Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
    Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2006

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2013 - 2025
  • NY State Medical License
    NY State Medical License Active through 2013

Publications & Presentations

PubMed

Abstracts/Posters

  • Quantifying the Economic Burden of Myelodysplastic Syndromes Among Elderly US Patients
    Katharine Batt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Economic Burden of Bronchiolitis Obliterans Syndrome (BOS) Following Allogeneic Hematopoietic Stem Cell Transplant (alloHSCT) in Patients with Commercial Insurance in ...
    Katharine Batt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • We Need More Studies of People with Mild Hemophilia
    We Need More Studies of People with Mild HemophiliaFebruary 25th, 2022
  • Takeda Drives Continued Scientific Leadership Through Real-World Evidence in Rare Hematological Diseases at ASH 2021
    Takeda Drives Continued Scientific Leadership Through Real-World Evidence in Rare Hematological Diseases at ASH 2021December 13th, 2021
  • ASH 2016 – Saturday, December 3
    ASH 2016 – Saturday, December 3December 3rd, 2015
  • Join now to see all

Hospital Affiliations